Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Leandro

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Genes & Diseases|November 11, 2025
Molecular profiling unveils genetic complexity and identifies potential new driver mechanisms in head and neck paragangliomasSara Mellid, Eduardo Caleiras, Ángel M Martínez-Montes, et al.
Human Molecular Genetics|February 19, 2013
Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosisIñaki Comino-Méndez, Aguirre A de Cubas, Carmen Bernal, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 14, 2015
Functional and in silico assessment of MAX variants of unknown significanceIñaki Comino-Méndez, Luis J Leandro-García, Guillermo Montoya, et al.
The American Journal of Pathology|December 4, 2012
Differential gene expression of medullary thyroid carcinoma reveals specific markers associated with genetic conditionsAgnieszka Maliszewska, Luis J Leandro-Garcia, Esmeralda Castelblanco, et al.
Nature Genetics|June 21, 2011
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytomaIñaki Comino-Méndez, Francisco J Gracia-Aznárez, Francesca Schiavi, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2020
CD133 Expression in Medullary Thyroid Cancer Cells Identifies Patients with Poor PrognosisAlfonso Cordero-Barreal, Eduardo Caleiras, Evangelina López de Maturana, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 29, 2025
Expression of Homo Sapiens (Hsa)-miR-139-5p as a Clinically Feasible Prognostic Marker for Differentiated Thyroid CancerNatalia Martínez-Puente, Ignacio Ruz-Caracuel, Luis J Leandro-García, et al.
International Journal of Cancer|August 13, 2019
Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicingCristina Montero-Conde, Osvaldo Graña-Castro, Guillermo Martín-Serrano, et al.
Cancers|October 13, 2021
Analysis of Telomere Maintenance Related Genes Reveals <i>NOP10</i> as a New Metastatic-Risk Marker in Pheochromocytoma/ParagangliomaMaría Monteagudo, Paula Martínez, Luis J Leandro-García, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|September 1, 2024
MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paragangliomaMaría Monteagudo, Bruna Calsina, Milton E Salazar-Hidalgo, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Genes & Diseases|November 11, 2025
Molecular profiling unveils genetic complexity and identifies potential new driver mechanisms in head and neck paragangliomasSara Mellid, Eduardo Caleiras, Ángel M Martínez-Montes, et al.
Human Molecular Genetics|February 19, 2013
Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosisIñaki Comino-Méndez, Aguirre A de Cubas, Carmen Bernal, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 14, 2015
Functional and in silico assessment of MAX variants of unknown significanceIñaki Comino-Méndez, Luis J Leandro-García, Guillermo Montoya, et al.
The American Journal of Pathology|December 4, 2012
Differential gene expression of medullary thyroid carcinoma reveals specific markers associated with genetic conditionsAgnieszka Maliszewska, Luis J Leandro-Garcia, Esmeralda Castelblanco, et al.
Nature Genetics|June 21, 2011
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytomaIñaki Comino-Méndez, Francisco J Gracia-Aznárez, Francesca Schiavi, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2020
CD133 Expression in Medullary Thyroid Cancer Cells Identifies Patients with Poor PrognosisAlfonso Cordero-Barreal, Eduardo Caleiras, Evangelina López de Maturana, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 29, 2025
Expression of Homo Sapiens (Hsa)-miR-139-5p as a Clinically Feasible Prognostic Marker for Differentiated Thyroid CancerNatalia Martínez-Puente, Ignacio Ruz-Caracuel, Luis J Leandro-García, et al.
International Journal of Cancer|August 13, 2019
Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicingCristina Montero-Conde, Osvaldo Graña-Castro, Guillermo Martín-Serrano, et al.
Cancers|October 13, 2021
Analysis of Telomere Maintenance Related Genes Reveals <i>NOP10</i> as a New Metastatic-Risk Marker in Pheochromocytoma/ParagangliomaMaría Monteagudo, Paula Martínez, Luis J Leandro-García, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|September 1, 2024
MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paragangliomaMaría Monteagudo, Bruna Calsina, Milton E Salazar-Hidalgo, et al.
Pageof 11